901459
Allyl poly(ethylene glycol)-block-poly(lactide-co-glycolide)
PEG average Mn 5000, PLGA average Mn 15000, lactide:glycolide (50:50)
Synonym(s):
Allyl-PEG-b-PLGA, Allyl-PEG-PLGA
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
C3H5O(C2H4O)n[(C2H2O2)x(C3H4O2)y]m
NACRES:
NA.23
UNSPSC Code:
51171641
description
Feed Ratio: 50:50+/-5 (Lactide:Glycolide, by NMR), Identity: Conforms to structure (by NMR)
form
powder
feed ratio
lactide:glycolide (50:50), lactide:glycolide±5 (50:50)
mol wt
PEG Mn 4000-6000 g/mol (NMR), PEG average Mn 5000, PLGA Mn 13500-16500 g/mol (NMR), PLGA average Mn 15000
color
white
storage temp.
−20°C
Application
Allyl poly(ethylene glycol)-block-poly(lactide-co-glycolide) is an allyl-functionalized, biocompatible, amphiphilic block copolymer. Due to its self-assembling properties, this material can be used in the formation of nanoparticles for drug delivery. Additionally, due to the allyl-functionalization of the PEG block, this material can be used to covalently conjugate biomolecules, API, or targeting ligands rapidly. Potential uses include the targeted and/or controlled release of cancer drugs, anti-inflammatory drugs, antibiotics, or anaesthetic agents.
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
>230.9 °F
flash_point_c
> 110.5 °C
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties and nanomedical applications as drug delivery system.
Locatelli E, et al.
Journal of Nanoparticle Research, 14, 1316-1316 (2012)
Polymer degradation and drug delivery in PLGA-based drug-polymer applications: A review of experiments and theories.
Xu Y, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials, 105, 1692-1716 (2017)
Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties and nanomedical applications as drug delivery system
Locatelli E, et al
Journal of Nanoparticle Research, 14, 1316-1316 (2012)
Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier.
Ilaria Monaco et al.
Journal of medicinal chemistry, 60(10), 4510-4516 (2017-05-05)
Polymeric nanoparticles (PNPs) may efficiently deliver in vivo therapeutics to tumors when conjugated to specific targeting agents. Gint4.T aptamer specifically recognizes platelet-derived growth factor receptor β and can cross the blood-brain barrier (BBB). We synthesized Gint4.T-conjugated PNPs able of high
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service